The award recognizes Jason McLellan’s work to investigate how viruses infect our cells and to develop new treatments for infectious disease.

Emin Ulug, retired Molecular Biosciences Associate Professor of Instruction passed away on September 12 after a long illness.

These antibodies use a clever trick to slip deep into a bacteria’s outer membrane, where they can do real damage.

Ken Keiler studies basic molecular biology with the aim of developing new antibiotics.

Discovery brings us one step closer to vaccine and treatment for prevalent virus.

McLellan, who will be inducted in Washington, D.C. on May 8, is among the youngest new inductees in hall of fame history.

Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection.

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as similar coronaviruses.

Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.

An innovative approach uses artificial intelligence and biosensors to pave the way for faster drug development.